Ionis reports fourth quarter and full year 2020 financial results and recent business achievements
Achieved 2020 financial guidance
Webcast today, February 24, 2021, at 9:00 a.m. Eastern Time
News provided by
Share this article
Share this article
CARLSBAD, Calif., Feb. 24, 2021 /PRNewswire/ Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the fourth quarter of 2020 and recent business highlights. Last year, we laid out a bold new vision for the Company and took important steps towards our goal of becoming one of the most successful biotechnology companies. Key to our vision is our strategy to maximize the value of our pipeline by commercializing our wholly owned medicines. Our acquisition of Akcea was an important step in building our commercial capabilities while enabling us to further strengthen our organization, said Brett P. Monia, Ph.D., chief executive officer at Ionis. Last year, we also advanced our late-stage pipeline and expand